R&D Cloud powering biotech research — experiments, samples, and lab data management.
Healthcare📍 San Francisco, USAFounded 2012
Current Valuation
$6.1B
as of 2021-Q4
UNICORN
IPO Outlookrumored
Is Benchling going public in 2026?
An IPO is rumored for 2026, with nothing filed. Benchling remains private and the date is not the company's.
What is Benchling's valuation in 2026?
Benchling is valued at $6.1B as of 2021-Q4, set by its Series F ($100M, Nov 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Benchling filed an S-1?
No public S-1 is on file for Benchling as of 08/23/2026; the IPO is rumored.
Who are Benchling's investors?
Benchling's investors include Altimeter Capital, Franklin Templeton, Tiger Global, Lone Pine Capital, Sequoia Capital, Benchmark and 1 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Benchling builds the leading R&D Cloud for biotechnology, used by thousands of labs to manage experiments, sample inventory, lab workflows, and bioregistries. The company was last valued at $6.1B in its November 2021 Series F and is widely viewed as an IPO candidate as biotech software consolidates.
Company Profile
CEO
Sajith Wickramasekara
Founded
2012
HQ
San Francisco, USA
Employees
~800
Total Raised
$412M
Est. Revenue
$185M (2023-Q4)
Last Round
Series F — $100M (Nov 2021) · Lead: Altimeter Capital
IPO Status
rumored
Fundraising Status
Series F · $100M · 4y 9mo ago
rumoredTotal raised $412M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$100M
Nov 2021
Altimeter Capital
—
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Benchling — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-08-19. Re-checked weekly.
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
50
via ashby
Product-build share
36%
engineering, research, product, design
Trajectory
strengthening
balanced build + GTM — 36% builders vs 64% go-to-market/G&A — scaling both sides.
Recent senior hire: 1 senior hire (CEO).
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INRey MaliCEO · 2026-07-24
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Software Engineer, Agents (Growth) Software Engineer, Full Stack (Enterprise Lifecycle) (High Seniority)Full Stack Engineer, Scientific AI ModelsSoftware Engineer, Full Stack (Enterprise Lifecycle)Product Manager, Developer PlatformGlobal Program Manager
Counted from Benchling's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Sajith WickramasekaraAshu Singhal
Investors
Altimeter Capital · Franklin Templeton · Tiger Global · Lone Pine Capital · Sequoia Capital · Benchmark · Thrive Capital
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.